Symposium Presenters

Tariq Ahmad, MD, Professor of Pediatrics, University of California San Francisco, Benioff Children's Hospital

Mario Browne, MPH, CHES, CDP, Associate Dean for Equity, Engagement, and Justice; Associate Professor, School of Pharmacy, University of Pittsburgh

Marilyn Bull, MD, FAAP, CPST, Neurodevelopmental Physician, Division of Developmental Pediatrics, Riley Hospital for Children, Indiana University Health

Peter Bulova, MD, Professor of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center

George Capone, MD, Director, Kennedy Krieger Institute's Down Syndrome Clinic and Research Center

Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency

Joaquin Espinosa, PhD, Anna and John J. Sie Chair in Genomics; Professor of Pharmacology; Executive Director - Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine – Anschutz Medical Campus

Katie Frank, PhD, OTR/L, Annual Symposium Committee Co-Chair; Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center

Hannah Graham, MD, Family Medicine Physician, Advocate Medical Group Adult Down Syndrome Center, Oak Brook, Illinois

James Hunt, MD, Adjunct Associate Professor of Anesthesiology, Department of Anesthesiology, UAMS COM, Division of Pediatric Anesthesiology and Pain Medicine, Arkansas Children's Hospital

Kristie Marble, DO, FAAP, Assistant Professor of Pediatrics, University of Missouri-Kansas City School of Medicine; Clinical Assistant Professor of Pediatrics, University of Kansas School of Medicine

Andrew McCormick, MD, Associate Professor of Pediatrics; Medical Director, University of Pittsburgh Medical Center Vascular Anomaly Center; Director, Healthy Transitions Program, Down Syndrome Center, University of Pittsburgh School of Medicine

Anthony McGovern, MS, OTR, CPST, Occupational Therapist, Indiana University School of Medicine

Dara Mendez, PhD, MPH, Associate Director of the Center for Health Equity; Associate Professor; Faculty in Epidemiology, School of Public Health, University of Pittsburgh

Jon Meyers, Executive Director, Arizona Developmental Disabilities Planning Council

Helen Milligan, PT, MPT, Physical Therapist, Physical Therapy Department, Children's Hospital of Philadelphia

Meghan O'Neill, MD, National Institutes of Health (NIH)

Melissa Parisi, MD, PhD, Chief, Intellectual & Developmental Disabilities Branch, DS-Connect® Registry Coordinator, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)

Lina Patel, PsyD, Director of Psychology at the Sie Center for Down Syndrome, Children's Hospital Colorado; Assistant Professor, University of Colorado School of Medicine

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Mary Stephens, MD, MPH, FAAFP, FAADM, Medical Director, Jefferson Continuing Care Program (JCCP), Associate Professor, Family and Community Medicine

Larry Suva, PhD, Professor and Head, Veterinary Physiology and Pharmacology, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University

Carolyn Tellalian, LCSW, Clinical Social Worker, Valley Children’s Healthcare, Madera, California

Kishore Vellody, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine

Symposium Planning Committee

Nicole Baumer, MD, MEd, Director, Boston Children's Hospital Down Syndrome Program

Gabriela Eguiarte, MD, Pediatrician, Angeles Pedregal Hospital, Mexico

Katie Frank, PhD, OTR/L, Annual Symposium Committee Co-Chair; Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center

Amy Lyle, MSSW, Clinic Coordinator, Waisman Down Syndrome Clinic, University of Wisconsin-Madison

Andrew McCormick, MD, Director, Healthy Transitions Program, Down Syndrome Center of Western Pennsylvania; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine

Meghan O'Neill, MD, FAAP, Attending Physician, Developmental and Behavioral Pediatrics; Attending Physician, Neurology, Lurie Children’s Hospital; Assistant Professor of Pediatrics (Developmental Behavioral Pediatrics, Child Neurology), Northwestern University Feinberg School of Medicine

Lina Patel, PsyD, Director of Psychology at the Sie Center for Down Syndrome, Children's Hospital Colorado; Assistant Professor, University of Colorado School of Medicine

Emilie Perkins, Director of Client and Conference Services, Raybourn Group International

Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center

Dannah Raz, MD, Interim Division Chief, Developmental Pediatrics, Barrow Neurological Institute of Phoenix Children's

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.